Literature DB >> 1987084

Enhancement of lipopolysaccharide-induced tumor necrosis factor production in mice by carrageenan pretreatment.

M Ogata1, S Yoshida, M Kamochi, A Shigematsu, Y Mizuguchi.   

Abstract

Tumor necrosis factor (TNF) is a cytokine which mediates endotoxin shock and causes multiple organ damage. It is thought that macrophage (MP) activation is necessary to increase lipopolysaccharide (LPS)-induced TNF production and lethality. Carrageenan (CAR) is sulfated polygalactose which destroys MP; it is used as a MP blocker. We found that CAR pretreatment can increase both endotoxin-induced TNF production and the mortality rate in mice. The ddY mice (7 to 8 weeks old) were injected intraperitoneally with CAR (5-mg dose) and challenged intravenously with LPS 24 h later. Without CAR pretreatment, LPS doses of less than 10 micrograms did not induce TNF in sera. After pretreatment, however, about 3 x 10(3) to 4 x 10(4) U of TNF per ml was produced after LPS injection at doses of 0.1 to 10 micrograms, respectively. TNF production was significantly increased by CAR pretreatment at LPS doses of more than 10 micrograms. CAR pretreatment rendered the mice more sensitive to the lethal effect of LPS; 50% lethal doses of LPS in CAR-pretreated mice and nonpretreated mice were 26.9 and 227 micrograms, respectively. The mortality of the two groups was significantly different at doses of 50, 100, and 200 micrograms of LPS. CAR increased LPS-induced TNF production and mortality within 2 h, much earlier than MP activators, which needed at least 4 days. Our results made clear that TNF production is enhanced not only by a MP activator but also by a MP blocker.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987084      PMCID: PMC257810          DOI: 10.1128/iai.59.2.679-683.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo.

Authors:  U F Schade; M Ernst; M Reinke; D T Wolter
Journal:  Biochem Biophys Res Commun       Date:  1989-03-15       Impact factor: 3.575

2.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

3.  Spectrum and possible mechanism of carrageenan cytotoxicity.

Authors:  P J Catanzaro; H J Schwartz; R C Graham
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

4.  BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.

Authors:  S N Vogel; R N Moore; J D Sipe; D L Rosenstreich
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

5.  Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.

Authors:  M M Hogan; S N Vogel
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

6.  Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.

Authors:  G Chaudhri; I A Clark
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  Increased toxicity of endotoxin for tumor-bearing mice and mice responding to bacterial pathogens: macrophage activation as a common denominator.

Authors:  M J Berendt; M F Newborg; R J North
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

9.  Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype.

Authors:  B Beutler; V Tkacenko; I Milsark; N Krochin; A Cerami
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.

Authors:  V Lehmann; M A Freudenberg; C Galanos
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  13 in total

1.  Escherichia coli lipopolysaccharide administration alters antioxidant profile during hypercholesterolemia.

Authors:  Kallol Dutta; Biswadev Bishayi
Journal:  Indian J Clin Biochem       Date:  2009-07-09

2.  Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice.

Authors:  M Ogata; T Matsumoto; M Kamochi; S I Yoshida; Y Mizuguchi; A Shigematsu
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Effects of nickel oxide on the production of tumor necrosis factor by alveolar macrophages of rats.

Authors:  Y Morimoto; Z Nambu; I Tanaka; T Higashi; H Yamato; H Hori; S Cho; M Kido
Journal:  Biol Trace Elem Res       Date:  1995-06       Impact factor: 3.738

4.  Carrageenan primes leukocytes to enhance lipopolysaccharide-induced tumor necrosis factor alpha production.

Authors:  M Ogata; T Matsui; T Kita; A Shigematsu
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice.

Authors:  T Matsumoto; M Ogata; K Koga; A Shigematsu
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.

Authors:  A K Franks; K I Kujawa; L J Yaffe
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

7.  An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.

Authors:  M Ogata; T Matsumoto; K Koga; I Takenaka; M Kamochi; T Sata; S Yoshida; A Shigematsu
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

8.  Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.

Authors:  K Takada; N Ohno; T Yadomae
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat liver after treatment with lipopolysaccharide.

Authors:  T Nagano; T Kita; N Tanaka
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

10.  Augmented expression of tumour necrosis factor-alpha induced by lipopolysaccharide in spleen of human monocyte chemoattractant protein-1 transgenic mouse enhances the lipopolysaccharide sensitivity of the marginal zone macrophages.

Authors:  Manabu Ato; Kazuya Iwabuchi; Shigeki Shimada; Naofumi Mukaida; Kazunori Onoé
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.